HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells trained to fight stubborn stomach virus in transplant patients
Disease control Recruiting nowThis early-stage trial tests whether giving specially trained immune cells (norovirus-specific T-cells) is safe for people with weakened immune systems who have a long-lasting norovirus infection. The study includes patients who have had a stem cell or organ transplant, or have a…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
Long-Term stem cell survivors: is hidden iron damaging your liver?
Knowledge-focused Recruiting nowThis study checks if too much iron in the body causes liver problems in people who had a stem cell transplant more than 10 years ago. About 500 adults will have their medical history reviewed and get a special liver scan. The goal is to learn if treating iron overload can prevent…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC